There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on December 4, Meridian Bioscience Inc.'s Exec VP, Operations & IS, Lawrence Baldini, invested $652,294.50 into 32,500 shares of VIVO, for a cost per share of $20.07.